Oncology Treatment Plan Updates in EPIC-Beacon

Authors

Rose DiMarco, PharmD, BCPS, BCOP, Thomas Jefferson UniversityFollow
Gloria Espinosa, MAT, PharmD, BCOP, Thomas Jefferson UniversityFollow
Kelly Miskovsky, PharmD, BCOP, Thomas Jefferson UniversityFollow
Gina Hemmert, PharmD, Thomas Jefferson UniversityFollow

Document Type

Poster

Presentation Date

5-3-2024

Comments

Presented at the 2024 Jefferson Health Equity and Quality Improvement (HEQI) Summit.

Abstract

Background

In Medical Oncology, the utilization of EPIC-Beacon Treatment Plans is integral for prescribing and administering cancer treatments. These treatment plans typically consist of anticancer infusion medications (chemotherapy, immunotherapy, etc.), supportive care medications, required laboratory orders, and other monitoring recommendations to ensure that patients receive safe and effective care. In 2017, TJUH transitioned from Varian’s Aria to EPIC’s electronic medical record system. Since then, there has not been a formal review of existing plans, and there are many inconsistencies between plans in different cancer types.

Problem Statement:

• Currently, there is not a formal process for review of existing treatment plans, and standardization efforts have been limited.

Project Aim:

• Establish standardized guidelines for all components of the EPICBeacon Treatment plans, perform a review of all standard-of-care EPICBeacon Treatment plans, and develop a process for future review.

Recommended Citation

DiMarco, PharmD, BCPS, BCOP, Rose; Espinosa, MAT, PharmD, BCOP, Gloria; Miskovsky, PharmD, BCOP, Kelly; and Hemmert, PharmD, Gina, "Oncology Treatment Plan Updates in EPIC-Beacon" (2024). Kimmel Cancer Center Papers, Presentations, and Grand Rounds. Paper 71.
https://jdc.jefferson.edu/kimmelgrandrounds/71

Language

English